Clinical Trials Logo

Bipolar Disorder clinical trials

View clinical trials related to Bipolar Disorder.

Filter by:

NCT ID: NCT02020200 Not yet recruiting - BD Clinical Trials

The Effect of Methylphenidate on Cognitive Abilities of Adults With Bipolar Disorder

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of the study is to explore the effect of MPH on working memory, attention and decision making in adults with BD in remission or in depressed state. The results will be compared to findings in healthy adults and adults with ADHD. The investigators hypothesize that MPH will incur improved performance in all measures.

NCT ID: NCT02015143 Enrolling by invitation - Bipolar Disorder Clinical Trials

A Comprehensive Assessment and Follow up Descriptive Study on Bipolar Disorder

CAFE-BD
Start date: January 2012
Phase: N/A
Study type: Observational

The purpose of this study was to investigate the reliability and validity of the bipolar index (BPX) to diagnosis bipolar disorder, and to verify the stability of it in identifying bipolar disorder; the secondary purpose was to understand the dynamic changes of bipolar disorder in natural status.

NCT ID: NCT02009371 Completed - Clinical trials for Depressive Episodes of Bipolar Disorder

A Clinical Study of Light Therapy on Depressive Episodes of Bipolar Disorder

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of light-emitting diode(LED) light therapy on Chinese patients with Depressive Episodes of Bipolar Disorder and to gather prime research data and application parameters of LED light source which is not currently available in China.

NCT ID: NCT02006862 Completed - Schizophrenia Clinical Trials

eVAluatIon of OLanzapine TreatmEnT

VIOLET
Start date: January 2014
Phase: N/A
Study type: Observational

This clinical observational study aims to investigate the efficacy of olanzapine (Villamos ®) in accordance with the instructions attached thereto in standard clinical practice, followed by the physician to the patient. This is a multicenter, non- interventional observational study , 6-month period without preparing the patient to take the usual his medication . A total of 3 scheduled visits : Visit 1 to Day 0 ( integration , base ) , Visit 2 at month 3 and Visit 3 at month 6 ( = end of treatment) . The purpose of the study is to demonstrate the efficacy and safety of olanzapine in patients who are indicated . Will be monitored and recorded all the different concomitant therapy . The treatment of each patient is an individual designated by the physician , according to standard clinical practice and without any intervention research purpose . During the six months of observation patients visit the clinic at the beginning (day 0 ), intermediate ( 3 months ) and end (month 6). The purpose of these visits is regularly monitored by their doctor for senile dementia and their behavior .

NCT ID: NCT02005367 Completed - Depression Clinical Trials

A Novel Person-Centered Treatment Component for Substance Use Treatment

Start date: June 2011
Phase: N/A
Study type: Interventional

A person-centered substance use treatment component, the Natural Recovery Program, was developed in a residential substance use treatment setting. The Natural Recovery Program is comprised of small group therapy combined with pursuit of hobbies. The study examined treatment retention, treatment completion and satisfaction of participants of Natural Recovery compared to those who participated in core residential treatment activities alone.

NCT ID: NCT02003690 Completed - Clinical trials for Standard of Care Psychotherapy + Pharmacotherapy

Dialectical Behavior Therapy (DBT) for Adolescents With Bipolar Disorder

DBT
Start date: November 18, 2014
Phase: N/A
Study type: Interventional

Of all psychiatric diagnoses, bipolar disorder imparts the greatest risk for completed suicide in adolescence, and is further associated with poor psychosocial functioning, substance abuse and legal difficulties, and exorbitant healthcare costs exceeding those for other adolescent psychiatric conditions. Treatment guidelines indicate optimal management of pediatric bipolar disorder includes a combination of medication and psychotherapy. Yet, little is known about effective psychotherapy approaches for this population, and none expressly target suicidality. An efficacious, cost-effective psychosocial intervention for adolescents with bipolar disorder has great potential to decrease the substantial morbidity, mortality and costs associated with adolescent bipolar disorder.

NCT ID: NCT01996293 Completed - Bipolar Disorder Clinical Trials

Pregnant Women Taking Lamictal for Bipolar Disorder

PK-LAPB
Start date: September 2013
Phase:
Study type: Observational

This study seeks to examine how the dose of lamotrigine (Lamictal) should be adjusted during pregnancy for women with Bipolar Disorder. The investigators predict that the concentration of Lamictal in women's blood will decrease during pregnancy, and increase after postpartum. Because the concentration of the medication is likely to decrease during pregnancy, it is important for doctors to know how much they should increase a patient's dose in order to prevent worsening of Bipolar symptoms. In this study, the investigators will ask that participants complete up to five overnight visits to our clinical research unit where their blood will be drawn every couple of hours, through an IV catheter, to measure how the concentration of lamotrigine (Lamictal) changes over time. Participants will be compensated for their time.

NCT ID: NCT01992393 Completed - Depression Clinical Trials

Targeted Self-Management for Epilepsy and Serious Mental Illness (TIME)

Start date: September 2013
Phase: N/A
Study type: Interventional

For this project we propose to refine the psychosocial intervention developed in phase one, based on input from key stakeholders, and to test the feasibility, acceptability and preliminary efficacy of the intervention. The proposed project addresses unmet public health needs for a historically hard-to-reach group of individuals with epilepsy and comorbid serious mental illnesses, and as the intervention is an adjunct to care that individuals with serious mental illness are already receiving, and uses staff already likely to be present in a care system, it is ideally suited for "real-world" implementation in people with epilepsy and serious mental illness (E-SMI). The purpose of this study is to try and engage individuals with E-SMI to actively participate in illness self-management and treatment adherence that are crucial in minimizing the morbidity and mortality associated with both chronic mental disorders and chronic neurological conditions.

NCT ID: NCT01992302 Completed - Bipolar Disorder Clinical Trials

Risk Factors for Development of Rapid Cycling in Bipolar Disorder Patients

Start date: June 2004
Phase: N/A
Study type: Observational

In this study we tried to elucidate the factors associated with the development of a rapid cycling course in bipolar disorder patients, in a prospective and longitudinal design, and the role of antidepressants. The identification of risk factors is extremely relevant from the clinical point of view. We hypothesized that rapid cycling bipolar disorder is associated with more chronicity, poor outcome, and more antidepressant prescription.

NCT ID: NCT01986101 Completed - Bipolar Depression Clinical Trials

A Phase III Study of SM-13496 in Patients With Bipolar I Depression.

Start date: February 19, 2014
Phase: Phase 3
Study type: Interventional

The study evaluates the efficacy and safety of SM-13496 compared with placebo in patients with Bipolar I Depression.